Understand the source comparison
Best Research Peptides for Tennis Elbow: Mechanism Comparison
BPC-157 VEGF upregulation, fibroblast migration Strong. Promotes neovascularization in hypovascular tendon tissue Moderate. Indirect via improved blood supply 250–500 mcg/day Daily subcutaneous Best first-line choice for chronic tendinopathy. Strongest angioge
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- BPC-157
- VEGF upregulation, fibroblast migration
- Strong. Promotes neovascularization in hypovascular tendon tissue
- Moderate. Indirect via improved blood supply
- 250–500 mcg/day
- Daily subcutaneous
- Best first-line choice for chronic tendinopathy. Strongest angiogenesis evidence
- TB-500
- Actin binding, cell migration, endothelial proliferation
- Moderate. Supports vessel formation
- Strong. Direct fibroblast recruitment to injury site
- 2–5 mg
- Twice weekly subcutaneous
- Essential for combination protocols. Mobilizes repair cells to damaged tissue
- GHK-Cu
- Fibroblast proliferation, cytokine modulation
- Mild. Indirect through reduced inflammation
- Strong. Directly upregulates Type I collagen gene expression
- 1–3 mg/day
- Best for remodeling phase (weeks 3–6). Enhances collagen maturation and cross-linking